2021 annual financial data
Heron Therapeutics, Inc. 2021 Operating margin
Heron Therapeutics, Inc. 2021 operating margin with verified reported values.
Direct answer
Operating margin was -252.27%.
Operating income was -217,828,000 USD and net income was -217,662,000 USD.
Operating cash flow was -203,354,000 USD.
Get free Heron Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 86,346,000 USD
- Operating income
- -217,828,000 USD
- Net income
- -217,662,000 USD
- Operating cash flow
- -203,354,000 USD